Page last updated: 2024-08-26

1-piperonylpiperazine and caffeic acid

1-piperonylpiperazine has been researched along with caffeic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, IO; Hwang, JS; Jang, M; Lee, SH; Park, JH; Park, SY	1

Other Studies

1 other study(ies) available for 1-piperonylpiperazine and caffeic acid

Article	Year
A novel caffeic acid-1-piperonylpiperazine hybridization compound HBU-47 inhibits LPS-mediated inflammation in RAW264.7 macrophage cells. International immunopharmacology, 2014, Volume: 19, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Cell Line; Cell Survival; Cyclooxygenase 2 Inhibitors; Cytokines; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Piperazines; RNA, Messenger	2014

Article

Year

A novel caffeic acid-1-piperonylpiperazine hybridization compound HBU-47 inhibits LPS-mediated inflammation in RAW264.7 macrophage cells.

International immunopharmacology, 2014, Volume: 19, Issue:1

Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Cell Line; Cell Survival; Cyclooxygenase 2 Inhibitors; Cytokines; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Piperazines; RNA, Messenger

2014